Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Paediatrics
1.2.3 Adolescence
1.2.4 Adults
1.2.5 Elderly
1.3 Market by Application
1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Seasonal Influenza Vaccines Therapeutics Market Perspective (2019-2030)
2.2 Seasonal Influenza Vaccines Therapeutics Growth Trends by Region
2.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Seasonal Influenza Vaccines Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Seasonal Influenza Vaccines Therapeutics Market Dynamics
2.3.1 Seasonal Influenza Vaccines Therapeutics Industry Trends
2.3.2 Seasonal Influenza Vaccines Therapeutics Market Drivers
2.3.3 Seasonal Influenza Vaccines Therapeutics Market Challenges
2.3.4 Seasonal Influenza Vaccines Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue
3.1.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Seasonal Influenza Vaccines Therapeutics Revenue
3.4 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio
3.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Therapeutics Revenue in 2023
3.5 Seasonal Influenza Vaccines Therapeutics Key Players Head office and Area Served
3.6 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
3.7 Date of Enter into Seasonal Influenza Vaccines Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Type
4.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2025-2030)
5 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Application
5.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
6.2 North America Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)
6.4 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)
7.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
9.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Seasonal Influenza Vaccines Therapeutics Introduction
11.1.4 GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Introduction
11.2.4 Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 CSL
11.3.1 CSL Company Detail
11.3.2 CSL Business Overview
11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Introduction
11.3.4 CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.3.5 CSL Recent Development
11.4 MedImmune
11.4.1 MedImmune Company Detail
11.4.2 MedImmune Business Overview
11.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Introduction
11.4.4 MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.4.5 MedImmune Recent Development
11.5 Sanofi-Pasteur
11.5.1 Sanofi-Pasteur Company Detail
11.5.2 Sanofi-Pasteur Business Overview
11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Introduction
11.5.4 Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.5.5 Sanofi-Pasteur Recent Development
11.6 Solvay
11.6.1 Solvay Company Detail
11.6.2 Solvay Business Overview
11.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Introduction
11.6.4 Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.6.5 Solvay Recent Development
11.7 Hualan Biological Engineering
11.7.1 Hualan Biological Engineering Company Detail
11.7.2 Hualan Biological Engineering Business Overview
11.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Introduction
11.7.4 Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.7.5 Hualan Biological Engineering Recent Development
11.8 Sinovac Biotech
11.8.1 Sinovac Biotech Company Detail
11.8.2 Sinovac Biotech Business Overview
11.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Introduction
11.8.4 Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.8.5 Sinovac Biotech Recent Development
11.9 Changchun Institute of Biological Products Co., Ltd.
11.9.1 Changchun Institute of Biological Products Co., Ltd. Company Detail
11.9.2 Changchun Institute of Biological Products Co., Ltd. Business Overview
11.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.9.4 Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Development
11.10 Shanghai Institute of Biological Products Co., Ltd.
11.10.1 Shanghai Institute of Biological Products Co., Ltd. Company Detail
11.10.2 Shanghai Institute of Biological Products Co., Ltd. Business Overview
11.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.10.4 Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2019-2024)
11.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details